MOACM
NVAX icon

Mutual of America Capital Management’s Novavax NVAX Stock Holding History

Mutual of America Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,467
Closed -$697K – 1634
2022
Q1 		$697K Sell
9,467
-354
-4% -$31.6K 0.01% 1076
2021
Q4 		$1.41M Sell
9,821
-80
-0.8% -$13.7K 0.01% 1030
2021
Q3 		$2.05M Buy
9,901
+1,187
+14% +$262K 0.02% 946
2021
Q2 		$1.85M Sell
8,714
-18,935
-68% -$3.47M 0.02% 997
2021
Q1 		$5.01M Buy
27,649
+6,752
+32% +$1.35M 0.05% 499
2020
Q4 		$2.33M Hold
20,897
– – 0.03% 841
2020
Q3 		$2.26M Buy
+20,897
New +$2.55M 0.03% 765

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mutual of America Capital Management's NVAX Position: Q2 2022 in Review

Mutual of America Capital Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 9,467 shares — an estimated $697K sold.

Mutual of America Capital Management first reported a position in NVAX in Q3 2020 and held it in 7 quarters. The position peaked at $5.01M in Q1 2021. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Mutual of America Capital Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 9,467 Novavax shares in Q2 2022, an estimated $697K.
  • Mutual of America Capital Management first reported a position in Novavax in Q3 2020 and held it in 7 quarters.
  • Mutual of America Capital Management's Novavax position peaked at $5.01M in Q1 2021.
  • 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Mutual of America Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.